| Source: |
| Type: |
| HSL is a lipolytic enzyme encoded by LIPE. It hydrolyzes stored lipid intermediates, especially diacylglycerol, releasing fatty acids for oxidation or signalling. In cancer, HSL can either supply fatty acids that support tumour metabolism or participate in lipid homeostasis that restrains abnormal lipid accumulation. Its expression and activity vary substantially by tumour type, so there is no reliable universal direction. |
| 6984- | Form, | Formononetin suppresses colitis-associated colon cancer by targeting lipid synthesis and mTORC2/Akt signaling |
| - | in-vitro, | Colon, | HCT116 | - | Review, | IBD, | RAW264.7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1549 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid